AAV2-mediated subretinal gene transfer of mIL-27p28 attenuates experimental autoimmune uveoretinitis in mice

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Shao, Ju ^a   Tian, Lichun ^a   Lei, Bo ^a   Wei, Lin ^a   Yang, Yan ^a   Kijlstra, Aize ^b   Yang, Peizeng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 27; INTERLEUKIN 27P28; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; EYE; IMMUNE RESPONSE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SERUM; SPLEEN; SUBRETINAL DRUG ADMINISTRATION; TISSUE HOMOGENATE; UVEORETINITIS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; AUTOIMMUNE DISEASES; DEPENDOVIRUS; EYE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKINS; MICE; RETINITIS;

MURINAE; MUS;

EID: 84861325097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037773     Document Type: Article

References (38)

1. Reeves SW, Sloan FA, Lee PP, Jaffe GJ, (2006) Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. Ophthalmology 113: 307 e301.
2. Edelsten C, Reddy MA, Stanford MR, Graham EM, (2003) Visual loss associated with pediatric uveitis in english primary and referral centers. Am J Ophthalmol 135: 676-680.
3. Gritz DC, Wong IG, (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111: 491-500; discussion 500.
4. Nussenblatt RB, Palestine AG, Rook AH, Scher I, Wacker WB, et al. (1983) Treatment of intraocular inflammatory disease with cyclosporin A. Lancet 2: 235-238.
5. Dick AD, Azim M, Forrester JV, (1997) Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. Br J Ophthalmol 81: 1107-1112.
6. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16: 779-790.
7. Pot C, Apetoh L, Awasthi A, Kuchroo VK, (2010) Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. J Interferon Cytokine Res 30: 381-388.
8. Rosas LE, Satoskar AA, Roth KM, Keiser TL, Barbi J, et al. (2006) Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am J Pathol 168: 158-169.
9. Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, et al. (2005) The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174: 3534-3544.
10. Pearl JE, Khader SA, Solache A, Gilmartin L, Ghilardi N, et al. (2004) IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol 173: 7490-7496.
11. Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, et al. (2008) Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 38: 1204-1214.
12. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, et al. (2008) Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 67: 1474-1479.
13. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, et al. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718.
14. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, et al. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7: 929-936.
15. Lee YS, Amadi-Obi A, Yu CR, Egwuagu CE, (2011) Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10. Immunology 132: 492-502.
16. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, et al. (1996) A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 70: 1143-1153.
17. Maaser C, Egan LJ, Birkenbach MP, Eckmann L, Kagnoff MF, (2004) Expression of Epstein-Barr virus-induced gene 3 and other interleukin-12-related molecules by human intestinal epithelium. Immunology 112: 437-445.
18. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, et al. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937-945.
19. Stumhofer JS, Tait ED, Quinn WJ, 3rd, Hosken N, Spudy B, et al. (2010) A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol 11: 1119-1126.
20. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, et al. (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358: 2231-2239.
21. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, et al. (2008) Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358: 2240-2248.
22. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, et al. (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19: 979-990.
23. Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, et al. (2008) Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A 105: 15112-15117.
24. Colella P, Cotugno G, Auricchio A, (2009) Ocular gene therapy: current progress and future prospects. Trends Mol Med 15: 23-31.
25. Annear MJ, Bartoe JT, Barker SE, Smith AJ, Curran PG, et al. (2011) Gene therapy in the second eye of RPE65-deficient dogs improves retinal function. Gene Ther 18: 53-61.
26. Barker SE, Broderick CA, Robbie SJ, Duran Y, Natkunarajah M, et al. (2009) Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice. J Gene Med 11: 486-497.
27. Broderick CA, Smith AJ, Balaggan KS, Georgiadis A, Buch PK, et al. (2005) Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. Mol Ther 12: 369-373.
28. Smith JR, Verwaerde C, Rolling F, Naud MC, Delanoye A, et al. (2005) Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Hum Gene Ther 16: 1037-1046.
29. Tian L, Yang P, Lei B, Shao J, Wang C, et al. (2011) AAV2-Mediated Subretinal Gene Transfer of hIFN-alpha Attenuates Experimental Autoimmune Uveoretinitis in Mice. PLoS One 6: e19542.
30. Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, et al. (2002) Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther 9: 804-813.
31. McKenzie BS, Kastelein RA, Cua DJ, (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27: 17-23.
32. Rizzo LV, Xu H, Chan CC, Wiggert B, Caspi RR, (1998) IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 10: 807-814.
33. Jankowski M, Kopinski P, Goc A, (2010) Interleukin-27: biological properties and clinical application. Arch Immunol Ther Exp (Warsz) 58: 417-425.
34. Oh HM, Yu CR, Lee Y, Chan CC, Maminishkis A, et al. (2011) Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J Immunol 187: 3338-3346.
35. Crabe S, Guay-Giroux A, Tormo AJ, Duluc D, Lissilaa R, et al. (2009) The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J Immunol 183: 7692-7702.
36. Lei B, Zhang K, Yue Y, Ghosh A, Duan D, (2009) Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer. Mol Vis 15: 1374-1382.
37. Caspi RR, (2003) Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol Chapter 15: Unit 15 16.
38. Itano N, Atsumi F, Sawai T, Yamada Y, Miyaishi O, et al. (2002) Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci U S A 99: 3609-3614.